BenQ Medical Technology (4116) — Cash Flow Quality Index
BenQ Medical Technology (4116) has a Cash Flow Quality Index of 18.36x as of June 2025. Operating cash flow of NT$179.07 Million exceeds net income of NT$9.76 Million, indicating high earnings quality where cash backs reported profits. Explore 4116 cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
BenQ Medical Technology Cash Flow Quality Index (2017–2024)
Historical Cash Flow Quality Index for BenQ Medical Technology across 8 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check BenQ Medical Technology investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for BenQ Medical Technology (2017–2024)
Year-by-year earnings quality comparison for BenQ Medical Technology. For live market cap and the full company financial profile, see BenQ Medical Technology (4116) market capitalisation.
| Year | Quality Index | Operating CF (TWD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.12x | NT$222.22 Million | NT$104.83 Million | ▼ -45.1% |
| 2023 | 3.86x | NT$442.35 Million | NT$114.58 Million | ▲ +83.7% |
| 2022 | 2.10x | NT$378.77 Million | NT$180.24 Million | ▲ +7.0% |
| 2021 | 1.96x | NT$121.35 Million | NT$61.78 Million | ▲ +37.0% |
| 2020 | 1.43x | NT$151.48 Million | NT$105.67 Million | ▲ +1.1% |
| 2019 | 1.42x | NT$169.23 Million | NT$119.30 Million | ▼ -25.0% |
| 2018 | 1.89x | NT$126.10 Million | NT$66.68 Million | ▲ +20.9% |
| 2017 | 1.56x | NT$72.97 Million | NT$46.63 Million | — |